-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BOaBKH9diy+gDLN1OnypzUN3WOsgaPdZVF7f7jnFnzLuAtyfSEMwSzp9QNApWKQ6 wopdfsh0Pq+pFeYqmq9lVQ== 0001144204-08-037716.txt : 20080630 0001144204-08-037716.hdr.sgml : 20080630 20080630184723 ACCESSION NUMBER: 0001144204-08-037716 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070209 FILED AS OF DATE: 20080630 DATE AS OF CHANGE: 20080630 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PAGANELLI JOHN A CENTRAL INDEX KEY: 0001236687 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-33528 FILM NUMBER: 08927243 BUSINESS ADDRESS: STREET 1: 4 TAFT COURT CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 585 586 8138 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Opko Health, Inc. CENTRAL INDEX KEY: 0000944809 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 752402409 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4400 BISCAYNE BLVD. STREET 2: SUITE 900 CITY: MIAMI STATE: FL ZIP: 33137 BUSINESS PHONE: 305-575-6015 MAIL ADDRESS: STREET 1: 4400 BISCAYNE BLVD. STREET 2: SUITE 900 CITY: MIAMI STATE: FL ZIP: 33137 FORMER COMPANY: FORMER CONFORMED NAME: eXegenics Inc DATE OF NAME CHANGE: 20040505 FORMER COMPANY: FORMER CONFORMED NAME: EXEGENICS INC DATE OF NAME CHANGE: 20011114 FORMER COMPANY: FORMER CONFORMED NAME: CYTOCLONAL PHARMACEUTICS INC /DE DATE OF NAME CHANGE: 19950503 4/A 1 v118726_ex.xml X0303 4/A 2007-02-09 2007-02-16 0 0000944809 Opko Health, Inc. OPK 0001236687 PAGANELLI JOHN A 1250 PITTSFORD - VICTOR ROAD BUILDING 200 - SUITE 280 PITTSFORD NY 14534 1 0 0 1 Interim CEO/Chair of the Board Common Stock, par value $0.01 2007-02-09 4 A 0 50000 0 A 100000 D The amount of securities beneficially owned by the reporting person was incorrectly reported as 155,000 shares due to the improper inclusion of stock options to purchase 55,000 shares. /s/ Kate Inman, Attorney-in-fact 2008-06-30 -----END PRIVACY-ENHANCED MESSAGE-----